Market Research Report
Prosthetic Heart Valve/ Artificial Heart Valve Market by Type (Transcatheter Heart Valve, Tissue Heart Valve, and Mechanical Heart Valve), and Region (North America, Europe, Asia-Pacific, and RoW) - Global Forecast to 2022
|Published by||MarketsandMarkets||Product code||352646|
|Published||Content info||159 Pages
Delivery time: 1-2 business days
|Prosthetic Heart Valve/ Artificial Heart Valve Market by Type (Transcatheter Heart Valve, Tissue Heart Valve, and Mechanical Heart Valve), and Region (North America, Europe, Asia-Pacific, and RoW) - Global Forecast to 2022|
|Published: June 5, 2017||Content info: 159 Pages||
"Prosthetic Heart Valves Market Projected to Grow at a CAGR of 12.9% in the Forecast Period (2017 to 2022)"
The prosthetic heart valves market is projected to reach USD 8.86 billion by 2022, at a CAGR of 12.9% from 2017 to 2022. The major factors driving the growth of this market include the rising geriatric population and the subsequent increase in the prevalence of HVD, regulatory approvals for new and advanced prosthetic heart valves, increasing government funding for heart valve research, rising awareness about HVD, and favorable reimbursement scenario for prosthetic heart valves.
Based on the type of valve, the prosthetic heart valves market is categorized as transcatheter heart valves, tissue heart valves, and mechanical heart valves. The transcatheter heart valves segment is expected to register the highest CAGR during the forecasting period. Factors such as the rising prevalence of aortic stenosis, increasing pool of patients owing to approvals for extended valve indications, and technological advancements are supporting the growth of this segment.
In 2017, North America is expected to dominate the prosthetic heart valves market, followed by Europe, Asia-Pacific, and the Rest of the World (RoW). This regional segment is also projected to register the highest CAGR during the forecast period. Factors such as the rapid growth in the aging population and prevalence of valvular heart diseases, favorable reimbursement scenario, and rising product approvals for heart valves are contributing to the growth of the North American prosthetic heart valves market.
The primary interviews conducted for this report can be categorized as follows:
The key players in this market are Medtronic plc (Ireland), Edwards Lifesciences Corporation (U.S.), Boston Scientific Corporation (U.S.), St. Jude Medical, Inc. (Abbott Laboratories Company) (U.S.), LivaNova PLC (U.K.), Symetis SA (Switzerland), Jenavalve Technology, Inc. (Germany), CryoLife, Inc. (U.S.), TTK Healthcare Limited (India), Colibri Heart Valve, LLC (U.S.), Lepu Medical Technology Co., Ltd. (China), and Braile Biomedica (Brazil).
The report analyses the prosthetic heart valves market by type of valve and region. Apart from comprehensive geographic analysis, market sizing and volume analysis, the report also provides a competitive landscape that covers the growth strategies adopted by industry players over the last three years. The company profiles section in the report comprises the product portfolios, developments, and strategies adopted by the market players to maintain and increase their shares in the market. The above-mentioned market research data, current market size, and forecast of the future trends will help key market players and new entrants to make the necessary decisions regarding product offerings, geographic focus, change in strategic approach, and levels of output in order to remain successful in the market.
The report will enable both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn helps firms to garner a greater market share. Firms purchasing the report could use any one or a combination of the below-mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) to strengthen their market shares.
The report provides insights on the following pointers:
Top 13 companies analysed for this study are - Edwards Lifesciences Corporation (U.S.), Medtronic plc (Ireland), St. Jude Medical, Inc. (Abbott Laboratories Company) (U.S.), Boston Scientific Corporation (U.S.), LivaNova PLC (U.K.), Symetis SA (Switzerland), JenaValve Technology, Inc. (Germany), CryoLife, Inc. (U.S.), TTK Healthcare Limited (India), Colibri Heart Valve, LLC (U.S.), Lepu Medical Technology Co., Ltd. (China), and Braile Biomedica (Brazil). Other players in this market include Micro Interventional Devices, Inc. (U.S.), Autotissue Berlin GmbH (Germany), Comed B.V. (Netherlands), Meril Life Sciences Pvt. Ltd. (India), Labcor Laboratorios Ltda. (Brazil), and HLT Inc. (A Bracco Group Company) (U.S.)
*Details on Overview, Products and Services, Financials, Strategy & Development might not be Captured in case of Unlisted Companies.